Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Accumulated Expenses (2019 - 2025)

Historic Other Accumulated Expenses for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to $2.6 million.

  • AVITA Medical's Other Accumulated Expenses rose 10053.07% to $2.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.6 million, marking a year-over-year increase of 10053.07%. This contributed to the annual value of $2.6 million for FY2025, which is 10053.07% up from last year.
  • Per AVITA Medical's latest filing, its Other Accumulated Expenses stood at $2.6 million for Q4 2025, which was up 10053.07% from $2.1 million recorded in Q3 2025.
  • AVITA Medical's Other Accumulated Expenses' 5-year high stood at $2.6 million during Q4 2025, with a 5-year trough of $949000.0 in Q2 2021.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $1.3 million (2023), whereas its average is $1.4 million.
  • Per our database at Business Quant, AVITA Medical's Other Accumulated Expenses plummeted by 4022.81% in 2024 and then skyrocketed by 11144.84% in 2025.
  • Quarter analysis of 5 years shows AVITA Medical's Other Accumulated Expenses stood at $1.1 million in 2021, then dropped by 7.91% to $990000.0 in 2022, then increased by 27.88% to $1.3 million in 2023, then grew by 4.19% to $1.3 million in 2024, then surged by 100.53% to $2.6 million in 2025.
  • Its Other Accumulated Expenses stands at $2.6 million for Q4 2025, versus $2.1 million for Q3 2025 and $1.8 million for Q2 2025.